Clinical Trial Update: Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing a Treatment Plan of Preoperative Chemotherapy and Radiation Therapy, Followed by Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of weekly epoetin alfa in patients with gastric or rectal cancers undergoing preoperative chemotherapy and radi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Rectal Cancer

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Stomach Neoplasms, Rectal Neoplasms | Phase 3 | Status: COMPLETED